Trial Profile
A Retrospective, Pilot study to evaluate the impact of CT morphology as an independent response marker for Regorafenib treatment in metastatic Colorectal Cancer patients with liver metastases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2018
Price :
$35
*
At a glance
- Drugs Regorafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 04 Sep 2018 New trial record